|
About the Events / Workshops / Webinars category
|
|
0
|
727
|
April 14, 2021
|
|
Register for Free Webinar- Australia and New Zealand: Nitrosamines Impurities 19 March 2026
|
|
0
|
171
|
March 10, 2026
|
|
Register for Quality Hour- Japan Edition: Nitrosamines Impurities 18 March 2026
|
|
0
|
173
|
March 8, 2026
|
|
N-nitroso-Duloxetine recall back in the news!
|
|
21
|
4630
|
March 7, 2026
|
|
The Bench Mark dose (BMD) - Recorded full two day training FREE
|
|
4
|
334
|
March 4, 2026
|
|
Podcast: Reducing Nitrosamines and Driving Patient Safety
|
|
0
|
134
|
February 23, 2026
|
|
Nitrites/Nitrosamines: The impacts on analytics, but not only
|
|
0
|
164
|
February 17, 2026
|
|
10th Impurities: Genotoxic, Nitrosamine, & Beyond Summit
|
|
2
|
346
|
February 2, 2026
|
|
Live Q&A hosted by Andy Teasdale
|
|
0
|
163
|
January 30, 2026
|
|
🇹🇷 USP is hosting a user event (and I will be there! 👨🔬)
|
|
4
|
286
|
January 20, 2026
|
|
🇪🇬 EDA Workshop: Nitrosamine Impurities, Risk Assessment, Control Strategies, and Regulatory Compliance
|
|
3
|
339
|
January 14, 2026
|
|
🇺🇸 FDA Information Session on Generic Drug Research Needs & Opportunities for FY 2026
|
|
0
|
241
|
January 12, 2026
|
|
Happy 2026 Nitroso-warrior!
|
|
5
|
437
|
January 9, 2026
|
|
Calling our Risk Assessment Experts
|
|
52
|
1701
|
December 30, 2025
|
|
Nitrosamine Bootcamp in Indonesia & Korea
|
|
0
|
236
|
November 4, 2025
|
|
Advancing Generic Drug Development: Translating Science to Approval 2025
|
|
3
|
443
|
October 10, 2025
|
|
Risk Assessment Tool community review -launch
|
|
5
|
917
|
August 22, 2025
|
|
Nitrosamines and NOx at AAPS in San Antonio November 25
|
|
1
|
225
|
August 20, 2025
|
|
🇺🇸 FDA - Fiscal Year 2024 Generic Drug Science and Research Initatives Public Workshop
|
|
21
|
2140
|
August 7, 2025
|
|
🇦🇷 Nitrosaminas en Fármacos. Academia Nacional de Farmacia y Bioquimica
|
|
0
|
197
|
July 1, 2025
|
|
Optimizing Pharmaceutical Formulations: Strategies for Improving Stability and Minimizing Nitrosamine Impurities-Webinar
|
|
1
|
344
|
June 20, 2025
|
|
🇲🇽 Free Lhasa México Symposia: Shaping the Future of Pharma & Regulation 🇲🇽
|
|
0
|
133
|
May 13, 2025
|
|
From Identification to Quantitation: A Complete Workflow for NDSRI Analysis
|
|
0
|
415
|
May 8, 2025
|
|
📅 Updates on Approaches to Acceptable Intakes of Nitrosamine Drug Substance Related Impurities (NDSRIs) and Bioequivalence Assessment for Reformulated Drug Products(CRCG)
|
|
39
|
3614
|
May 2, 2025
|
|
HSA Industry Training Workshop 2024 - Management of Nitrosamine Impurities in Therapeutic Products
|
|
2
|
336
|
April 29, 2025
|
|
FDA Generic Drugs Forum - Bioequivalence Approaches
|
|
2
|
1030
|
April 22, 2025
|
|
Generic Drugs Forum (GDF) 2025
|
|
5
|
1033
|
April 19, 2025
|
|
:brazil: Lhasa Brazil Symposium: Aligning Pharma & Regulatory Standards Globally :brazil:
|
|
0
|
154
|
April 3, 2025
|
|
Dr. Andrew Teasdale on the recent updates on Nitrosamine Impurities - Virtual Workshop
|
|
1
|
697
|
March 15, 2025
|
|
Nitrosoureas and beyond: What to do when the CPCA doesn’t apply
|
|
0
|
409
|
March 5, 2025
|